Gossamer Bio's total assets for Q2 2025 were $240.93M, a decrease of -14.14% from the previous quarter. GOSS total liabilities were $287.03M for the fiscal quarter, a 0.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.